28544-93-6 Usage
Uses
Used in Chemical Synthesis:
1,4-dioxepan-6-one is used as a reactant for the synthesis of spiro ether herbicides, which are a class of compounds that exhibit herbicidal properties. These herbicides are employed in agriculture to control the growth of unwanted plants, thereby increasing crop yield and quality.
1,4-dioxepan-6-one is also used as a reactant for the synthesis of spiroheterocycl-dihydropteridinones, which are complex organic molecules with potential applications in various fields, including pharmaceuticals and materials science. The unique structure of these compounds allows for the exploration of their potential uses in drug development and other advanced applications.
Check Digit Verification of cas no
The CAS Registry Mumber 28544-93-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,5,4 and 4 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 28544-93:
(7*2)+(6*8)+(5*5)+(4*4)+(3*4)+(2*9)+(1*3)=136
136 % 10 = 6
So 28544-93-6 is a valid CAS Registry Number.
InChI:InChI=1/C5H8O3/c6-5-3-7-1-2-8-4-5/h1-4H2
28544-93-6Relevant articles and documents
TRI-CYCLE COMPOUND AND APPLICATIONS THEREOF
-
, (2020/01/22)
Disclosed in the present invention are a compound represented by formula (I), a tautomer thereof or a pharmaceutically acceptable salt, and applications thereof in the preparation of drugs for treating HBV-related diseases.
APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
-
, (2014/09/30)
Disclosed herein are compounds that inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases using the compounds.
NEW 5-ALKYNYL-PYRIDINES
-
, (2012/08/08)
The present invention relates to new CGRP-antagonists of general formula I wherein R1, R2, R3, Ra, Rb, Rc, X, Y and Z are defined as mentioned hereinafter, the individual diastereomers, the individual enantiomers and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, medicaments containing these compounds, the use thereof and processes for the preparation thereof.